|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Differential effects on bone density of progestogen-only methods for |
| contraception in premenopausal women. |
| Naessen T; Olsson SE; Gudmundson J |
| CONTRACEPTION. 1995 Jul;52(1):35-9. |
| Researchers randomly allocated 22 premenopausal women aged 20-45 to treatment with either Depo-Provera (150 |
| mg depot-medroxyprogesterone acetate [DMPA] injected intramuscularly every 3 months) or Norplant (30-60 g |
| levonorgestrel/day during 1st year of use) to determine the differences in the short-term effects (at 6 months) on bone |
| mass and bone metabolism. The women, clients of the Family Planning Unit of the University Hospital in Uppsala, |
| Sweden, gave their informed consent to try either of the types of continuous progestogen contraception. The |
| researchers examined biochemical indices for bone metabolism. Alkaline phosphatase and osteocalcin increased |
| significantly in the levonorgestrel group (1.88-2.26 mckat/l [p = 0.004] and 1.22-3.05 mcg/l [p = 0.007], respectively). |
| DMPA increased bone turnover (serum calcium: 2.33-2.38 [p = 0.038]; urine hydroxyproline/creatinine ratio: 12.1-24) |
| and bone formation (serum osteocalcin: 1.2-1.61). Women treated with levonorgestrel experienced a 2.94% increase |
| in forearm bone mineral density (BMDprox) (p = 0.006), while women treated with DMPA experienced an insignificant |
| 0.41% decrease in BMDprox. These changes in BMDprox corresponded with the changes in the biochemical indices |
| for bone metabolism. These findings reveal that treatment with levonorgestrel at standard clinical doses for |
| contraception increases bone density, while treatment with DMPA at standard clinical doses for contraception does |
| not affect bone density. (PubHealth.info Document ID: CONT2T 2539-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Differential effects on bone density of progestogen-only |
| methods for contraception in premenopausal women.", is(are) Naessen T; Olsson SE; Gudmundson J. The source |
| of this article is "CONTRACEPTION. 1995 Jul;52(1):35-9.". This article was published in 1995 in English |
| language(s). (PubHealth.info® Document ID: CONT2T 2539-06. All rights reserved with PubHealth.info) PIN: 7539 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |